Prostate cancer

Prostate cancer (also known as carcinoma of the prostate) develops in the prostate, a gland in the male reproductive system and is one of the most common cancers among men. In many cases, cancerous cells infiltrate the surrounding prostatic capsule area, making a radical prostatectomy impossible. Thus, in approx. 50% of post-surgery patients, microscopic remnants of the tumor can still be found. Other common side effects of a prostatectomy include urinary incontinence and erectile dysfunction.

Radiation therapy is at an advantage here. When ist comes to the chance of recovery, there are no differences between a radical prostatectomy and radiotherapy. Thanks to technological progress, it is now possible to apply radiation doses of up to 80 Gy, thus improving the patient’s chances of recovery.

Due to highly adavanced radiotherapy, it is possible to irradiate the prostate with millimetric accuracy. This minimizes the risk of damage to the bladder and rectum while eliminating other grave side effects. Therefore, radiotherapy is a gentle alternative to prostatectomy. Many patients remain permanently free of symptoms after a radiotherapeutic treatment of the prostate.

At Dr. Adrian Staab’s new Centre for Radiotherapy, patients are treated with a state-of-the-art linear accelerator. This highly innovative technology is only being used in very few specialist centres throughout Germany.

The so-called RapidArc® Technology

  • reduces the duration of a treatment session significantly from 20 – 30 minutes down to about 5 minutes
  • enables a more accurate and time-saving treatment compared to conventional irradiation units
  • reduces side-effects due to the precise and fast irradiation treatment
  • significantly improves the patient’s comfort


When treating prostate cancer, advanced and patient-friendly radiotherapy is a viable alternative to surgery.
Side-effects prove to be rare after irradiation of a prostate carcinoma.
Many patients remain permanently symptom-free after a radiotherapeutic treatment of the prostate.